Insmed to Announce 2005 Fourth Quarter and Year End Financial Results; Thursday, March 2

The Company will host a conference call on Thursday, March 2 at4:30 p.m. Eastern Time to discuss operating results for the 2005fiscal year, and provide a business update.

Interested investors can listen to the call over the internet fromInsmed's investor relations website at www.insmed.com or by dialing800-289-0529 (domestic) or 913-981-5523 (international).

A telephonic replay of the call will be available for one week at888-203-1112 (domestic) or 719-457-0820 (international), passcode:4436753. A web replay of the call will be available through thecorporate website beginning at 6:00 p.m.

About Insmed Incorporated

Insmed Incorporated is a biopharmaceutical company focused on thedevelopment and commercialization of drug candidates for the treatmentof metabolic diseases and endocrine disorders with unmet medicalneeds. For further information about Insmed please visit the company'scorporate website at www.insmed.com.